| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |